Email ID
Password
Scrip   
US woes hurt Sun's Q2 profits as it makes fresh charges against Taro
02 November 2009
Anju Ghangurde

Sun Pharmaceutical Industries has reported an 11.5% decline in net profits to Rs4.54 billion ($95.8 million) for the second quarter ended September 30th, hurt by US FDA action against its US subsidiary over certain current good manufacturing practice (cGMP) violations.

Net sales increased...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36